AVR Healthcare

Anteris Technologies Global Corp.

$5.60-3.11%

Price as of close on Nov 3, 2026 · Financials updated Nov 1, 2026

Basics

Sector: Healthcare
Industry: Medical Devices
Country: Australia
Market cap: 545.8M USD
Enterprise value: 340.2M USD
Full-time employees: 174

Overall health

Drawback: less profitable than most peersless profitable than peers
Drawback: growing more slowly than most peersgrowing more slowly than peers
Drawback: its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings

Ranks #967 of 1,157 healthcare companies (bottom 17%)

See how it ranks against its peers

Worth knowing

Valuation signals disagree. Cheaper than 50% of peers on free cash flow, but only 0% on earnings.
Relative to its free cash flow, Anteris Technologies Global looks cheaper than 50% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.
Not profitable yet. Reported a loss in the 12 months to June 2026.
Anteris Technologies Global reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.
Revenue is falling. Revenue fell 9.6% in the 12 months to June 2026 vs the 12 months before.
Anteris Technologies Global's revenue fell 9.6% in the 12 months to June 2026 vs the 12 months before.
Little borrowing. Debt is 0.00× equity vs a peer median of 0.2×.Debt is 0.00× equity vs peers 0.2×.
Anteris Technologies Global has among the least debt in its peer group relative to shareholders' equity.

StockQuotient Score

31/ 100

Oct 5 31 → Nov 4 31

Valuation

Is the price right?

8/100

Weak

3/3 inputs reported · High confidence

Since last quarter: No major changeValuation also moves with the share price every day.

Why

Weaker than most peers on:

▼ Earnings yield
▼ EBITDA yield

Compare with peers

Behind the score

Sector-normalized EBITDA, earnings, and free cash flow yields.

Earnings yield-19.0%

SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price30% base weight · Z-score -1.00Sector median: 0.0148 · MAD: 0.0148

EBITDA yield-35.3%

SEC filings · 12 months to Jun 2026Negative (a loss or cash outflow), so it counts as zero whatever the share price50% base weight · Z-score -1.00Sector median: 0.0401 · MAD: 0.0401

Free cash flow yield-16.2%

SEC filings · 12 months to Jun 2026 · operating cash flow − capital spendingNegative (a loss or cash outflow), so it counts as zero whatever the share price20% base weight · Z-score 0.00Sector median: 0.0000 · MAD: 0.0000

Other data (not scored)

Book yield46.1%

SEC filings · latest balance sheetReported valueInformational · 0% composite weightSector median: 0.3716 · MAD: 0.2313

Growth

Is it growing?

16/100

Weak

3/3 inputs reported · High confidence

Since last quarter: ▲ Stronger

12-month revenue up 21.1%

Why

Weaker than most peers on:

▼ 3-yr revenue
▼ Revenue growth

Compare with peers

Behind the score

Revenue and earnings-per-share growth over one year, and revenue growth over three years.

Earnings per share growthUnavailable

Still loss-making, but the loss per share narrowed33% base weight · Z-score 0.29Sector median: 0.0976 · MAD: 0.2991

3-year revenue growth-15.1%

Yahoo Finance fallback · SEC figure unavailable or out of date · 3 fiscal years to Dec 2025Reported value33% base weight · Z-score -2.49Sector median: 0.0584 · MAD: 0.0840

Revenue growth-9.6%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -1.61Sector median: 0.0609 · MAD: 0.0974

Profitability

Does it earn well?

2/100

Weak

3/3 inputs reported · High confidence

Since last quarter: No major change

Why

Weaker than most peers on:

▼ Operating margin
▼ ROIC
▼ ROA

Compare with peers

Behind the score

Return on invested capital, operating margin, and return on assets.

Operating margin-4738.4%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentile33% base weight · Z-score -71.87Sector median: 0.0706 · MAD: 0.1217

Return on assets-38.0%

SEC filings · 12 months to Jun 2026Reported value33% base weight · Z-score -7.39Sector median: 0.0166 · MAD: 0.0537

Return on invested capital-4339.4%

SEC filings · 12 months to Jun 2026Outlier capped at sector 5th/95th percentile33% base weight · Z-score -16.87Sector median: 0.0471 · MAD: 0.1004

Other data (not scored)

Gross margin75.0%

SEC filings · 12 months to Jun 2026Reported valueInformational · 0% composite weightSector median: 0.4697 · MAD: 0.2310

Return on equity-41.2%

SEC filings · 12 months to Jun 2026Reported valueInformational · 0% composite weightSector median: 0.0330 · MAD: 0.1225

Risk

Debt, liquidity, price swings

Lower

Lower relative risk

2/3 inputs reported · Partial data

Since last quarter: ▲ Stronger

Debt down 38%

Why

Stronger than most peers on:

▲ Debt / equity
▲ Current ratio

Compare with peers

Behind the score

Relative to sector peers: 0 = lower relative risk · 1 = moderate · 2 = higher. Based on leverage, beta and liquidity.

BetaUnavailable

Missing · left out of the score · no sector data, so not countedNot counted · remaining weights rescaledSector median: 0.6250 · MAD: 0.3380

Current ratio14.20×

SEC filings · latest balance sheetReported value33% base weight · Z-score 8.38Sector median: 2.5860 · MAD: 1.3850

Debt / equity<0.01×

SEC filings · latest balance sheetOutlier capped at sector 5th/95th percentile33% base weight · Z-score 1.07Sector median: 0.2215 · MAD: 0.2039

Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.

Questions investors ask about Anteris Technologies Global

Is Anteris Technologies Global getting weaker?: Its latest SEC filing (Aug 11, 2026) got stronger: debt down 38%. Its overall score is unchanged at 31/100 since Oct 28, 2026.
How is Anteris Technologies Global valued vs its peers?: Priced higher than most peers relative to what it earns. Valuation scores 8/100 against 1,393 healthcare peers. Earnings yield -19.0% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -19.0% vs peers 1.5% (weaker than 100% of peers).
Is Anteris Technologies Global growing?: More slowly than most of its peers. Growth scores 16/100 against 1,393 healthcare peers. 3-year revenue growth -15.1% vs a peer median of 5.8% (weaker than 92% of peers).3-year revenue growth -15.1% vs peers 5.8% (weaker than 92% of peers).
How profitable is Anteris Technologies Global?: Less profitable than most of its peers. Profitability scores 2/100 against 1,393 healthcare peers. Operating margin -4738.4% vs a peer median of 7.1% (weaker than 100% of peers).Operating margin -4738.4% vs peers 7.1% (weaker than 100% of peers).
How risky is Anteris Technologies Global?: Lower risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity <0.01× vs a peer median of 0.22× (stronger than 95% of peers).Debt / equity <0.01× vs peers 0.22× (stronger than 95% of peers). A relative measure, not a bankruptcy probability.

Latest filing: what changed

Quarter ended Jun 30, 2026 · filed Aug 11, 2026 · compared with the quarter ended Mar 31, 2026

Got stronger

Debt down 38%

Worth watching: Anteris Technologies Global is in the bottom fifth of its sector on profitability. From 2021 to 2025, 63% of companies in that position posted a loss over the following year, against 4% for the top fifth.

	Previous quarter	Latest quarter	Change
Revenue (12 months)	1.9M USD	2.2M USD	+21.1%
Net income (12 months)	−95.3M USD	−103.6M USD	+8.7%
Operating margin	-5192.9%	-4738.4%	+454.6 pts
Free cash flow (12 months)	−86.8M USD	−88.2M USD	+1.6%
Debt	725,000 USD	451,000 USD	−37.8%
Cash	283.2M USD	249.9M USD	−11.8%
Shares outstanding	97.3M	97.5M	+0.1%

From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.

Financials

Fiscal years from SEC annual filings · change vs the prior year

Key ratios	FY 2024	FY 2025	Change
Gross margin	46.8%	70.3%	▲ 23 pts
Operating margin	-2899.4%	-4908.2%	▼ >999 pts
Net margin	-2822.5%	-4921.3%	▼ >999 pts
Return on assets (ROA)	-94.5%	-409.4%	▼ 315 pts
Return on equity (ROE)	-121.6%	—	—
Free cash flow margin	-2349.5%	-4169.2%	▼ >999 pts
Current ratio	4.51×	0.73×	▼ 84%
Quick ratio	4.48×	0.73×	▼ 84%
Debt to equity	0.00×	—	—
Interest coverage	-1667.49×	-1286.22×	▲ 23%

AVR price history

Price history is added with the daily price update and will appear after the next one.

Similar companies

Sector leaderboards

BB Biotech AGBBZA.DE100/ 100

Arbutus Biopharma CorporationABUS97/ 100

Q32 Bio Inc.QTTB97/ 100

Bringing the fundamentals into focus…

Overall health

Drawback: less profitable than most peersless profitable than peers

Drawback: growing more slowly than most peersgrowing more slowly than peers

Drawback: its shares are priced higher than most peers relative to what it earnspriced higher than peers for its earnings

Ranks #967 of 1,157 healthcare companies (bottom 17%)

See how it ranks against its peers

Worth knowing

Valuation signals disagree. Cheaper than 50% of peers on free cash flow, but only 0% on earnings.

Relative to its free cash flow, Anteris Technologies Global looks cheaper than 50% of peers; relative to its earnings, cheaper than only 0%. The valuation score blends the two, so look at which measure fits this business best.

Not profitable yet. Reported a loss in the 12 months to June 2026.

Anteris Technologies Global reported a net loss over the last twelve months, so earnings-based measures can't show it as cheap.

Revenue is falling. Revenue fell 9.6% in the 12 months to June 2026 vs the 12 months before.

Anteris Technologies Global's revenue fell 9.6% in the 12 months to June 2026 vs the 12 months before.

Little borrowing. Debt is 0.00× equity vs a peer median of 0.2×.Debt is 0.00× equity vs peers 0.2×.

Anteris Technologies Global has among the least debt in its peer group relative to shareholders' equity.

Questions investors ask about Anteris Technologies Global

Is Anteris Technologies Global getting weaker?

Its latest SEC filing (Aug 11, 2026) got stronger: debt down 38%. Its overall score is unchanged at 31/100 since Oct 28, 2026.

How is Anteris Technologies Global valued vs its peers?

Priced higher than most peers relative to what it earns. Valuation scores 8/100 against 1,393 healthcare peers. Earnings yield -19.0% vs a peer median of 1.5% (weaker than 100% of peers).Earnings yield -19.0% vs peers 1.5% (weaker than 100% of peers).

Is Anteris Technologies Global growing?

More slowly than most of its peers. Growth scores 16/100 against 1,393 healthcare peers. 3-year revenue growth -15.1% vs a peer median of 5.8% (weaker than 92% of peers).3-year revenue growth -15.1% vs peers 5.8% (weaker than 92% of peers).

How profitable is Anteris Technologies Global?

Less profitable than most of its peers. Profitability scores 2/100 against 1,393 healthcare peers. Operating margin -4738.4% vs a peer median of 7.1% (weaker than 100% of peers).Operating margin -4738.4% vs peers 7.1% (weaker than 100% of peers).

How risky is Anteris Technologies Global?

Lower risk relative to 1,393 healthcare peers, judged on debt, liquidity and share-price swings. Debt / equity <0.01× vs a peer median of 0.22× (stronger than 95% of peers).Debt / equity <0.01× vs peers 0.22× (stronger than 95% of peers). A relative measure, not a bankruptcy probability.

Previous quarter

Latest quarter

Change

Revenue (12 months)

1.9M USD

2.2M USD

+21.1%

Net income (12 months)

−95.3M USD

−103.6M USD

+8.7%

Operating margin

-5192.9%

-4738.4%

+454.6 pts

Free cash flow (12 months)

−86.8M USD

−88.2M USD

+1.6%

Debt

725,000 USD

451,000 USD

−37.8%

Cash

283.2M USD

249.9M USD

−11.8%

Shares outstanding

97.3M

97.5M

+0.1%

Key ratios

FY 2024

FY 2025

Change

Gross margin

46.8%

70.3%

▲ 23 pts

Operating margin

-2899.4%

-4908.2%

▼ >999 pts

Net margin

-2822.5%

-4921.3%

▼ >999 pts

Return on assets (ROA)

-94.5%

-409.4%

▼ 315 pts

Return on equity (ROE)

-121.6%

—

Free cash flow margin

-2349.5%

-4169.2%

▼ >999 pts

Current ratio

4.51×

0.73×

▼ 84%

Quick ratio

4.48×

0.73×

▼ 84%

Debt to equity

0.00×

—

Interest coverage

-1667.49×

-1286.22×

▲ 23%